Older age, overall comorbidities, low CD4 T-cell count, and non-tenofovir ART were associated with higher rates of oxygen requirement in the first model, but further adjustment mainly by chronic kidney disease showed no impact of tenofovir therapy in this outcome (model 2). Here, CD4 is linked to chronic kidney disease.